Cargando…

Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction

Glucose is a universally available inexpensive biomarker, which is increased as part of the physiological stress response to acute myocardial infarction (AMI) and may therefore help in its early diagnosis. To test this hypothesis, glucose, high-sensitivity cardiac troponin (hs-cTn) T, and hs-cTnI we...

Descripción completa

Detalles Bibliográficos
Autores principales: Yufera-Sanchez, Ana, Lopez-Ayala, Pedro, Nestelberger, Thomas, Wildi, Karin, Boeddinghaus, Jasper, Koechlin, Luca, Rubini Gimenez, Maria, Sakiz, Hüseyin, Bima, Paolo, Miro, Oscar, Martín-Sánchez, F. Javier, Christ, Michael, Keller, Dagmar I., Gualandro, Danielle M., Kawecki, Damian, Rentsch, Katharina, Buser, Andreas, Mueller, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480296/
https://www.ncbi.nlm.nih.gov/pubmed/37670005
http://dx.doi.org/10.1038/s41598-023-37093-1
_version_ 1785101763918954496
author Yufera-Sanchez, Ana
Lopez-Ayala, Pedro
Nestelberger, Thomas
Wildi, Karin
Boeddinghaus, Jasper
Koechlin, Luca
Rubini Gimenez, Maria
Sakiz, Hüseyin
Bima, Paolo
Miro, Oscar
Martín-Sánchez, F. Javier
Christ, Michael
Keller, Dagmar I.
Gualandro, Danielle M.
Kawecki, Damian
Rentsch, Katharina
Buser, Andreas
Mueller, Christian
author_facet Yufera-Sanchez, Ana
Lopez-Ayala, Pedro
Nestelberger, Thomas
Wildi, Karin
Boeddinghaus, Jasper
Koechlin, Luca
Rubini Gimenez, Maria
Sakiz, Hüseyin
Bima, Paolo
Miro, Oscar
Martín-Sánchez, F. Javier
Christ, Michael
Keller, Dagmar I.
Gualandro, Danielle M.
Kawecki, Damian
Rentsch, Katharina
Buser, Andreas
Mueller, Christian
author_sort Yufera-Sanchez, Ana
collection PubMed
description Glucose is a universally available inexpensive biomarker, which is increased as part of the physiological stress response to acute myocardial infarction (AMI) and may therefore help in its early diagnosis. To test this hypothesis, glucose, high-sensitivity cardiac troponin (hs-cTn) T, and hs-cTnI were measured in consecutive patients presenting with acute chest discomfort to the emergency department (ED) and enrolled in a large international diagnostic study (NCT00470587). Two independent cardiologists centrally adjudicated the final diagnosis using all clinical data, including serial hs-cTnT measurements, cardiac imaging and clinical follow-up. The primary diagnostic endpoint was index non-ST-segment elevation MI (NSTEMI). Prognostic endpoints were all-cause death, and cardiovascular (CV) death or future AMI, all within 730-days. Among 5639 eligible patients, NSTEMI was the adjudicated final diagnosis in 1051 (18.6%) patients. Diagnostic accuracy quantified using the area under the receiver-operating characteristics curve (AUC) for the combination of glucose with hs-cTnT and glucose with hs-cTnI was very high, but not higher versus that of hs-cTn alone (glucose/hs-cTnT 0.930 [95% CI 0.922–0.937] versus hs-cTnT 0.929 [95% CI 0.922–0.937]; glucose/hs-cTnI 0.944 [95% CI 0.937–0.951] versus hs-cTnI 0.944 [95% CI 0.937–0.951]). In early-presenters, a dual-marker strategy (glucose < 7 mmol/L and hs-cTnT < 5/hs-cTnI < 4 ng/L) provided very high and comparable sensitivity to slightly lower hs-cTn concentrations (cTnT/I < 4/3 ng/L) alone, and possibly even higher efficacy. Glucose was an independent predictor of 730-days endpoints. Our results showed that a dual marker strategy of glucose and hs-cTn did not increase the diagnostic accuracy when used continuously. However, a cutoff approach combining glucose and hs-cTn may provide diagnostic utility for patients presenting ≤ 3 h after onset of symptoms, also providing important prognostic information.
format Online
Article
Text
id pubmed-10480296
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-104802962023-09-07 Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction Yufera-Sanchez, Ana Lopez-Ayala, Pedro Nestelberger, Thomas Wildi, Karin Boeddinghaus, Jasper Koechlin, Luca Rubini Gimenez, Maria Sakiz, Hüseyin Bima, Paolo Miro, Oscar Martín-Sánchez, F. Javier Christ, Michael Keller, Dagmar I. Gualandro, Danielle M. Kawecki, Damian Rentsch, Katharina Buser, Andreas Mueller, Christian Sci Rep Article Glucose is a universally available inexpensive biomarker, which is increased as part of the physiological stress response to acute myocardial infarction (AMI) and may therefore help in its early diagnosis. To test this hypothesis, glucose, high-sensitivity cardiac troponin (hs-cTn) T, and hs-cTnI were measured in consecutive patients presenting with acute chest discomfort to the emergency department (ED) and enrolled in a large international diagnostic study (NCT00470587). Two independent cardiologists centrally adjudicated the final diagnosis using all clinical data, including serial hs-cTnT measurements, cardiac imaging and clinical follow-up. The primary diagnostic endpoint was index non-ST-segment elevation MI (NSTEMI). Prognostic endpoints were all-cause death, and cardiovascular (CV) death or future AMI, all within 730-days. Among 5639 eligible patients, NSTEMI was the adjudicated final diagnosis in 1051 (18.6%) patients. Diagnostic accuracy quantified using the area under the receiver-operating characteristics curve (AUC) for the combination of glucose with hs-cTnT and glucose with hs-cTnI was very high, but not higher versus that of hs-cTn alone (glucose/hs-cTnT 0.930 [95% CI 0.922–0.937] versus hs-cTnT 0.929 [95% CI 0.922–0.937]; glucose/hs-cTnI 0.944 [95% CI 0.937–0.951] versus hs-cTnI 0.944 [95% CI 0.937–0.951]). In early-presenters, a dual-marker strategy (glucose < 7 mmol/L and hs-cTnT < 5/hs-cTnI < 4 ng/L) provided very high and comparable sensitivity to slightly lower hs-cTn concentrations (cTnT/I < 4/3 ng/L) alone, and possibly even higher efficacy. Glucose was an independent predictor of 730-days endpoints. Our results showed that a dual marker strategy of glucose and hs-cTn did not increase the diagnostic accuracy when used continuously. However, a cutoff approach combining glucose and hs-cTn may provide diagnostic utility for patients presenting ≤ 3 h after onset of symptoms, also providing important prognostic information. Nature Publishing Group UK 2023-09-05 /pmc/articles/PMC10480296/ /pubmed/37670005 http://dx.doi.org/10.1038/s41598-023-37093-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Yufera-Sanchez, Ana
Lopez-Ayala, Pedro
Nestelberger, Thomas
Wildi, Karin
Boeddinghaus, Jasper
Koechlin, Luca
Rubini Gimenez, Maria
Sakiz, Hüseyin
Bima, Paolo
Miro, Oscar
Martín-Sánchez, F. Javier
Christ, Michael
Keller, Dagmar I.
Gualandro, Danielle M.
Kawecki, Damian
Rentsch, Katharina
Buser, Andreas
Mueller, Christian
Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction
title Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction
title_full Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction
title_fullStr Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction
title_full_unstemmed Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction
title_short Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction
title_sort combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480296/
https://www.ncbi.nlm.nih.gov/pubmed/37670005
http://dx.doi.org/10.1038/s41598-023-37093-1
work_keys_str_mv AT yuferasanchezana combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction
AT lopezayalapedro combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction
AT nestelbergerthomas combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction
AT wildikarin combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction
AT boeddinghausjasper combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction
AT koechlinluca combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction
AT rubinigimenezmaria combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction
AT sakizhuseyin combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction
AT bimapaolo combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction
AT mirooscar combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction
AT martinsanchezfjavier combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction
AT christmichael combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction
AT kellerdagmari combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction
AT gualandrodaniellem combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction
AT kaweckidamian combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction
AT rentschkatharina combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction
AT buserandreas combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction
AT muellerchristian combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction
AT combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction